Which of the following statements about romosozumab is FALSE?
Romosozumab is a monoclonal antibody against sclerostin. Denosumab is monoclonal antibody against RANK ligand. Romosozumab has dual action in osteoporosis. It stimulates osteoblast as well as inhibits osteoclast. It is used for treatment of post menopausal osteoporosis.
It is a monoclonal antibody against RANK ligand
It acts by inhibiting osteoclast
It acts by stimulating osteoblast
It is indicated in post menopausal osteoporosis
Osteoporosis, Sex Hormones and OCPs